loadpatents
name:-0.03066086769104
name:-0.01075291633606
name:-0.012707948684692
Kariolis; Mihalis Patent Filings

Kariolis; Mihalis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kariolis; Mihalis.The latest application filed is for "modified axl peptides and their use in inhibition of axl signaling in anti-metastatic therapy".

Company Profile
12.11.27
  • Kariolis; Mihalis - San Mateo CA
  • KARIOLIS; Mihalis - South San Francisco CA
  • Kariolis; Mihalis - Stanford CA
  • - Stanford CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20220220458 - Giaccia; Amato J. ;   et al.
2022-07-14
Formulations Of Protein Molecules Comprising Iduronate 2-sulfatase
App 20220184186 - ANDERSEN; Dana ;   et al.
2022-06-16
Anti-trem2 Antibodies And Methods Of Use Thereof
App 20220177576 - Dennis; Mark S. ;   et al.
2022-06-09
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy
Grant 11,136,563 - Giaccia , et al. October 5, 2
2021-10-05
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20210198640 - Astarita; Giuseppe ;   et al.
2021-07-01
Transferrin Receptor-binding Polypeptides And Uses Thereof
App 20210130485 - Dennis; Mark S. ;   et al.
2021-05-06
Antifibrotic activity of GAS6 inhibitor
Grant 10,876,176 - Tabibiazar , et al. December 29, 2
2020-12-29
Fusion proteins comprising enzyme replacement therapy enzymes
Grant 10,870,837 - Henry , et al. December 22, 2
2020-12-22
Engineered Transferrin Receptor Binding Polypeptides
App 20200369746 - Chen; Xiaocheng ;   et al.
2020-11-26
Albumin Variants For Enhanced Serum Half-life
App 20200317749 - Dennis; Mark S. ;   et al.
2020-10-08
Affinity-based Methods For Using Transferrin Receptor-binding Proteins
App 20200289627 - Dennis; Mark S. ;   et al.
2020-09-17
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20200277584 - ASTARITA; Giuseppe ;   et al.
2020-09-03
Engineered Polypeptides
App 20200262890 - Chen; Xiaocheng ;   et al.
2020-08-20
Engineered Transferrin Receptor Binding Polypeptides
App 20200223935 - Chen; Xiaocheng ;   et al.
2020-07-16
Engineered polypeptides
Grant 10,457,717 - Chen , et al. Oc
2019-10-29
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20190249155 - Henry; Anastasia ;   et al.
2019-08-15
Engineered Polypeptides
App 20180237496 - Chen; Xiaocheng ;   et al.
2018-08-23
Modulation Of Axl Receptor Activity In Combination With Cytoreductive Therapy
App 20180140679 - Giaccia; Amato J. ;   et al.
2018-05-24
Inhibition Of Axl/gas6 Signaling In The Treatment Of Liver Fibrosis
App 20180094034 - O'Connor; Patrick ;   et al.
2018-04-05
Antifibrotic Activity Of Gas6 Inhibitor
App 20180057898 - Tabibiazar; Raymond ;   et al.
2018-03-01
Modified Axl Peptides And Their Use In Inhibition Of Axl Signaling In Anti-metastatic Therapy
App 20180030422 - Giaccia; Amato J. ;   et al.
2018-02-01
Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
Grant 9,879,061 - O'Connor , et al. January 30, 2
2018-01-30
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy
Grant 9,822,347 - Giaccia , et al. November 21, 2
2017-11-21
High-affinity Binding To Gas6
App 20160266136 - Cochran; Jennifer R. ;   et al.
2016-09-15
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20160108378 - Giaccia; Amato J. ;   et al.
2016-04-21
Inhibition of AXL signaling in anti-metastatic therapy
Grant 9,266,947 - Giaccia , et al. February 23, 2
2016-02-23
Inhibition of AXL Signaling in Primary Tumor Therapy
App 20150315552 - Giaccia; Amato J. ;   et al.
2015-11-05
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20150315553 - Giaccia; Amato J. ;   et al.
2015-11-05
Inhibition of AXL signaling in anti-metastatic therapy
Grant 9,074,192 - Giaccia , et al. July 7, 2
2015-07-07
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20140065143 - Giaccia; Amato J. ;   et al.
2014-03-06
Inhibition of AXL signaling in anti-metastatic therapy
Grant 08618254 -
2013-12-31
Inhibition of AXL signaling in anti-metastatic therapy
Grant 8,618,254 - Giaccia , et al. December 31, 2
2013-12-31
Inhibition of AXL/GAS6 Signaling in the Treatment of Disease
App 20130189254 - O'Connor; Patrick ;   et al.
2013-07-25
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20130108644 - Giaccia; Amato J. ;   et al.
2013-05-02
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20130017205 - Giaccia; Amato J. ;   et al.
2013-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed